Set overview
Brilliant Stars is worth reviewing through raw price, graded price and break-even grade, not popularity alone. Brilliant Stars from the Sword & Shield series, released on 2022-02-25, includes 172 official cards and 216 total cards in the source data. Kardive keeps that set identity visible: Sword & Shield series, released 2022-02-25, 172 official cards, 216 total cards listed.
- Arceus VSTAR #184 - Secret Rare, Colorless
- Arceus VSTAR #176 - Secret Rare, Colorless
- Charizard VSTAR #174 - Secret Rare, Fire
- Galarian Moltres V #183 - Secret Rare, Darkness
- Galarian Zapdos V #182 - Secret Rare, Fighting
- Galarian Articuno V #181 - Secret Rare, Psychic
- Arceus VSTAR #123 - Holo Rare VSTAR, Colorless
- Mimikyu VMAX #069 - Holo Rare VMAX, Psychic
Card mix and identity
In the visible sample, rarity context includes Secret Rare, Holo Rare VSTAR, Holo Rare VMAX and Ultra Rare; where type data is available, cards include Colorless, Fire, Darkness and Fighting. Illustrator data such as the cards currently listed gives the pages more identity than name and number alone.
- Arceus VSTAR #184
- Arceus VSTAR #176
- Charizard VSTAR #174
- Galarian Moltres V #183
- Galarian Zapdos V #182
- Galarian Articuno V #181
- Arceus VSTAR #123
- Mimikyu VMAX #069
What to analyze
A set page should help users spot top raw cards, top graded cards, best ROI candidates and low-pop or scarcity candidates once live pricing is connected in the Kardive app.
- Raw value leaders
- PSA 10 upside candidates
- Cards that still work in PSA 9
- Cards to track before grading
How this connects to the app
In the full app, users can move from Brilliant Stars research to card detail, run an ROI calculation, save a scenario, create a watchlist item or add an owned position to portfolio.
- Open card detail
- Run ROI
- Save scenario
- Track in watchlist
User intent captured
People searching for Brilliant Stars grading ideas are usually weighing popularity against financial upside. Kardive keeps those separate, so a popular card still has to pass the fee and risk test.
